AzTrials
AzTrials

Tonsillar HypertrophyNCT07205653

Self-assessment of Tonsil Size

An observational study of Tonsillar Hypertrophy, run by Turku University Hospital at 1 site in Finland.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The participants receive instructions on two tonsil size classification scales and then, using a tongue depressor as well as their mobile phone camera and/or a flashlight and a mirror, the participants assess the size of their own tonsils on two scales. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Tonsillar Hypertrophy
How many people
90 participants
Where
1 siteFinland
Study dates
20 Oct 2025to 1 Jan 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: University first year medical students without any clinical or anatomical experience.

Who may be able to join

None listed.

Who cannot join

  • Experience in clinical work with patients
  • Prior tonsillectomy

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Finland1 site
  • Turku University Hospital

    Turku

    Henrik M Sjoblom, M.D., name.lastname@varha.fi

Other trials in Finland

About this study

Official title: Validity of Patients' Self-assessment of Tonsil Size

The participants receive instructions on two tonsil size classification scales and then, using a tongue depressor as well as their mobile phone camera and/or a flashlight and a mirror, the participants assess the size of their own tonsils on two scales.

After the self-assessment, a medical student and two ear, nose, and throat (ENT) specialists evaluate the participants' tonsil size using a tongue depressor and a headlamp, applying the same scales.

The objective of this study is to demonstrate that patient self-assessment constitutes a sufficiently accurate method for evaluating tonsil size. Furthermore, it aims to show that patients experiencing conditions such as sleep apnea or swallowing difficulties can, on the basis of their own assessment, be appropriately referred to an otolaryngologist for surgical evaluation, thereby conserving healthcare resources and reducing the time burden for patients.

Read the detailed description

A total of 70 to 100 medical students from the first to third year of study will be recruited beginning in 2025, with recruitment extended into 2026 if necessary. Participants will be provided with a plain-language summary of the research plan and will be asked to provide written informed consent to participate.

The investigators hypothesize that both participants and a trained medical student will be able to assess tonsil size-categorizing them as small, medium, or large, as well as grading them on a 0-4 scale-with sufficient agreement compared to professional evaluation, defined as an intraclass correlation coefficient (ICC) of at least 0.60.

Keywords
tonsil size, tonsillar hypertrophy, self-assessment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Sufficient intraclass correlation coefficient

    The investigators hypothesize that both participants and a trained medical student will be able to assess tonsil size-categorizing them as small, medium, or large, as well as grading them on a 0-4 scale-with sufficient agreement compared to professional evaluation, defined as an intraclass correlation coefficient (ICC) of at least 0.60.

    Measured: At enrollment (day 1)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Oct 2025
  2. Study start20 Oct 2025 (estimated)
  3. Primary completion1 Jan 2026 (estimated)
  4. Study completion1 Jan 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
90 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07205653
Sponsor's protocol ID
T2025/10790
Status last verified
Oct 2025
First submitted
24 Sep 2025
Last updated
3 Oct 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Tonsillar Hypertrophy, run by Turku University Hospital at 1 site in Finland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 0 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 3 Oct 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Finland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Sufficient intraclass correlation coefficient (time frame: At enrollment (day 1)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Oct 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in